Retevmo
selpercatinib · Tablet, Coated · Oral
No FDA structured label text is available for Retevmo. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Selpercatinib in 6 products
Retevmo NDC products (6)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 0002-2980 | Selpercatinib 80 mg/1 Capsule | Eli Lilly and Company | NDA |
| 0002-3977 | Selpercatinib 40 mg/1 Capsule | Eli Lilly and Company | NDA |
| 0002-5340 | Selpercatinib 40 mg/1 Tablet, Coated | Eli Lilly and Company | NDA |
| 0002-5562 | Selpercatinib 160 mg/1 Tablet, Coated | Eli Lilly and Company | NDA |
| 0002-6082 | Selpercatinib 80 mg/1 Tablet, Coated | Eli Lilly and Company | NDA |
| 0002-6120 | Selpercatinib 120 mg/1 Tablet, Coated | Eli Lilly and Company | NDA |
Frequently asked questions
Who makes Retevmo?
Retevmo is listed by 1 labeler in the FDA NDC directory, including Eli Lilly and Company.